Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARCH Venture Partners
Biotech
Arch closes $3B-plus fund to foster biopharma upstarts
On the heels of Bain's $3 billion fund, Arch Venture Partners has closed a VC fund of "more than $3 billion."
Fraiser Kansteiner
Sep 26, 2024 10:24am
Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days
Sep 24, 2024 7:00am
ArsenalBio raises $325M, pivots away from former lead asset
Sep 4, 2024 8:00am
Bob Nelsen on megarounds, Altos and psychedelics
May 1, 2024 10:56am
New AI drug discovery powerhouse Xaira rises with $1B in funding
Apr 24, 2024 6:00am
Arch-backed obesity biotech launches with $290M
Apr 18, 2024 7:00am